Dermatol. praxi. 2018;12(3):112-116 | DOI: 10.36290/der.2018.020

Psoriasis in children and interdisciplinary cooperation

MUDr. Kateřina Jůzlová, Ph.D., MUDr. Filip Rob, prof. MUDr. Jana Hercogová, CSc.
Dermatovenerologická klinika Nemocnice Na Bulovce a 2. LF UK, Praha

Psoriasis is currently considered to be a systemic disease that is manifested not only in the skin and joints, but is also associatedwith cardiovascular diseases, gastrointestinal diseases, and psychiatric complaints. Psoriasis comorbidities are typically mentionedin the context of adult patients. The aim of this article is to contribute to the awareness of psoriasis comorbidities in children notonly among dermatologists, but also among paediatricians, rheumatologists, gastroenterologists, and cardiologists, thus encouraginginterdisciplinary collaboration since diagnosing these diseases early can prevent subsequent complications and improvethe quality of life of children with psoriasis and their families.

Keywords: psoriasis in children, psoriatic arthritis, overweight and obesity, cardiovascular diseases, inflammatory bowel diseases,
psychiatric complaints

Published: October 10, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jůzlová K, Rob F, Hercogová J. Psoriasis in children and interdisciplinary cooperation. Dermatol. praxi. 2018;12(3):112-116. doi: 10.36290/der.2018.020.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Jůzlová K, Boháč P, Hercogová J. Léčba psoriázy u dětí. Čes dermatoven 2015, roč. 5, č. 3, s. 159-166.
    2. BRONCKERS IM, PALLER AS, van GEEL, MJ, et al. Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities. Paediatr Drugs, 2015, June 14. Go to original source... Go to PubMed...
    3. Pinson R, Sotoodian B, Fiorillo L. Psoriasis in children. Psoriasis (Auckl). 2016 Oct 20;6: 121-129. Go to original source... Go to PubMed...
    4. Paller A, Mancini A. Hurwitz Clinical Pediatric Dermatology, 4th edition, Elsevier, 2011.
    5. Bučková H, Polášková S. Psoriáza dětí. Čes-slov Derm, 2013, 88, s. 57-103.
    6. Tollefson MM, Van Houten HK, Asante D, Yao X, Maradit Kremers H. Association of Psoriasis With Comorbidity Development in Children With Psoriasis.JAMA Dermatol. 2018 Mar 1; 154(3): 286-292. Go to original source... Go to PubMed...
    7. Osier E, Wang AS, Tollefson MM, Cordoro KM, Daniels SR, Eichenfield A, Gelfand JM, Gottlieb AB, Kimball AB, Lebwohl M, Mehta NN, Paller AS, Schwimmer JB, Styne DM, Van Voorhees AS, Tom WL, Eichenfield LF. Pediatric Psoriasis Comorbidity Screening Guidelines. JAMA Dermatol. 2017 Jul 1; 153(7): 698-704. Go to original source... Go to PubMed...
    8. Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011-2014. NCHS Data Brief. 2015; (219): 1-8.
    9. Paller AS, Mercy K, Kwasny MJ, et al. Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. JAMA Dermatol. 2013; 149(2): 166-176. Go to original source... Go to PubMed...
    10. Becker L, Tom WL, Eshagh K, Benjamin LT, Paller AS. Excess adiposity preceding pediatric psoriasis. JAMA Dermatol. 2014; 150(5): 573-574. Go to original source... Go to PubMed...
    11. Toussirot E., Aubin F., Dumoulin G. Relationships between Adipose Tissue and Psoriasis, with or without Arthritis. Front Immunol. 2014 Aug 12; 5: 368.) Go to original source... Go to PubMed...
    12. Azfar RS, Seminara NM, Shin DB, Troxel AB, Margolis DJ, Gelfand JM. Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis. Arch Dermatol. 2012; 148(9): 995-1000. Go to original source... Go to PubMed...
    13. Tom WL, Playford MP, Admani S, et al. Characterization of lipoprotein composition and function in pediatric psoriasis reveals a more atherogenic profile. J Invest Dermatol. 2016; 136(1): 67-73. Go to original source... Go to PubMed...
    14. Gutmark-Little I, Shah KN. Obesity and the metabolic syndrome in pediatric psoriasis. Clin Dermatol. 2015; 33(3): 305-315. Go to original source... Go to PubMed...
    15. Salahuddin T, Natarajan B, Playford MP, et al. Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis. Eur Heart J. 2015; 36(39): 2662-2665. Go to original source... Go to PubMed...
    16. Abedini R, Salehi M, Lajevardi V, Beygi S. Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease. Clin Exp Dermatol. 2015; 40(7): 722-727. Go to original source... Go to PubMed...
    17. Juzlova K, Votrubova J, Dzambova M, Gopfertova D, Hercogova J, Smerhovsky Z. Gastrointestinal comorbidities in patients with psoriasis in the Czech Republic: The results of 189 patients with psoriasis and 378 controls. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Mar;160(1):100-105. doi: 10.5507/bp.2015.048. Epub 2015 Oct 21 Go to original source... Go to PubMed...
    18. Kimball AB, Wu EQ, Guérin A, et al. Risks of developing psychiatric disorders in pediatric patients with psoriasis. J Am Acad Dermatol. 2012; 67(4): 651-657. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.